New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

March 2006

March 16

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

Yaz (drospirenone and ethinyl estradiol) FDA Approval History
March 16

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

Yaz (drospirenone and ethinyl estradiol) FDA Approval History
March 16

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

Yaz (drospirenone and ethinyl estradiol) FDA Approval History

New Drug Approvals Archive

More News Resources

Advertisement
Close

Recommended

(web6)